These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 1437150)

  • 1. Differential induction of c-fos and c-jun proto-oncogenes and AP-1 activity by tumor promoter 12-O-tetradecanoyl phorbol 13-acetate in cells at different stages of tumor promotion in vitro.
    Wu WS; Lin JK; Wu FY
    Oncogene; 1992 Nov; 7(11):2287-94. PubMed ID: 1437150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of phorbol ester-induced monocytic differentiation by dexamethasone is associated with down-regulation of c-fos and c-jun (AP-1).
    Hass R; Brach M; Kharbanda S; Giese G; Traub P; Kufe D
    J Cell Physiol; 1991 Oct; 149(1):125-31. PubMed ID: 1939341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic phorbol ester treatment on protein kinase C activity, content, and gene expression in the human monoblastoid U937 cell.
    Ways DK; Qin W; Garris TO; Chen J; Hao E; Cooper DR; Usala SJ; Parker PJ; Cook PP
    Cell Growth Differ; 1994 Feb; 5(2):161-9. PubMed ID: 8180129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of c-fos and c-jun mRNA expression by basic fibroblast growth factor in cultured rat Müller cells.
    Cao W; Li F; Steinberg RH; LaVail MM
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):565-73. PubMed ID: 9501868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C activation and protooncogene expression in differentiation/retrodifferentiation of human U-937 leukemia cells.
    Hass R; Pfannkuche HJ; Kharbanda S; Gunji H; Meyer G; Hartmann A; Hidaka H; Resch K; Kufe D; Goppelt-Strübe M
    Cell Growth Differ; 1991 Nov; 2(11):541-8. PubMed ID: 1814434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of oncogene-induced transformation by a deletion mutant of c-jun.
    Brown PH; Alani R; Preis LH; Szabo E; Birrer MJ
    Oncogene; 1993 Apr; 8(4):877-86. PubMed ID: 8455942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fos and Jun form cell specific protein complexes at the neuropeptide tyrosine promoter.
    Jalava A; Mai S
    Oncogene; 1994 Aug; 9(8):2369-75. PubMed ID: 8036020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of jun family gene expression by the tumor promoter okadaic acid.
    Schönthal A; Alberts AS; Frost JA; Feramisco JR
    New Biol; 1991 Oct; 3(10):977-86. PubMed ID: 1662987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
    Jansen AP; Colburn NH; Verma AK
    Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of AP-1 transcription factor components during T-cell activation by interleukin 1 and phorbol esters.
    Yoza BK; Brooks JW; Mizel SB
    Cell Growth Differ; 1992 Oct; 3(10):677-84. PubMed ID: 1445798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
    Su ZZ; Yemul S; Stein CA; Fisher PB
    Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling pathways in the induction of c-fos and c-jun proto-oncogenes by 3-methylcholanthrene.
    Ainbinder E; Bergelson S; Daniel V
    Recept Signal Transduct; 1997; 7(4):279-89. PubMed ID: 9633828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Aminopurine abolishes EGF- and TPA-stimulated pp33 phosphorylation and c-fos induction without affecting the activation of protein kinase C.
    Mahadevan LC; Wills AJ; Hirst EA; Rathjen PD; Heath JK
    Oncogene; 1990 Mar; 5(3):327-35. PubMed ID: 2107492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
    Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
    Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing activities of c-Fos and Fra-2 on AP-1 regulated transcriptional activity in mouse keratinocytes induced to differentiate by calcium and phorbol esters.
    Rutberg SE; Saez E; Lo S; Jang SI; Markova N; Spiegelman BM; Yuspa SH
    Oncogene; 1997 Sep; 15(11):1337-46. PubMed ID: 9315102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of immortalization upon the induction of matrix metalloproteinases in rabbit synovial fibroblasts.
    Lin CW; Robbins PD; Georgescu HI; Evans CH
    Exp Cell Res; 1996 Feb; 223(1):117-26. PubMed ID: 8635483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AP-1 (Fos-Jun) regulation by IP-1: effect of signal transduction pathways and cell growth.
    Auwerx J; Sassone-Corsi P
    Oncogene; 1992 Nov; 7(11):2271-80. PubMed ID: 1437149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alpha-lipoic acid and dihydrolipoic acid on expression of proto-oncogene c-fos.
    Mizuno M; Packer L
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1136-42. PubMed ID: 8179594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and inhibition of the AP-1 complex in human breast cancer cells.
    Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
    Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K; Colburn NH
    Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.